INTERNSHIP 1

By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.

EXERCISE 1

GENERAL
REQUIREMENTS FOR
ISSUANCE OF LTO
BY BFAD

TERMS TO DEFINE
PHARMACY
DRUGS
POISON

CODE
BIOLOGIC PRODUCTS
WHOLESALER
DEVICE
CIPHER

 SECRET KEYS
PHARMACEUTICAL MEDICINES

REQUIREMENTS FOR OPENING A

DRUGSTORE UNDER PREMISES
Signboard
Well ventilated area nlt 15 sq.m.
Compounding area, sterilization area

Storage area for drugs

Cabinet ( poisons, DD)
Water supplies

REQUIREMENTS FOR OPENING A

DRUGSTORE
UNDER
UTENSILS,
APPARATUS, & EQUIPMENT
Refrigerator

BIO-REF

REQUIREMENTS FOR RENEWAL

OF LTO
Standard Petition Form name, citizenship,

picture, proposed area

Proof of registration

Single proprietorship cert. of business name

registration (BDT of DTI)
Partnerships, corporations cert. of
registration (SEC) and articles of Incorporation
or partnership

REQUIREMENTS FOR
DRUGSTORE/RETAIL OUTLET FOR
NON-RX DRUGS

Notarized petition/Joint affidavit

Tentative list of products
Floor area (nlt 15 sq.m)
Generic white and red labels
Rubber stamp of outlets
Pharmacist

Registration cert.
PRC-ID
valid PTR
ID picture
cert. of attendance to BFAD seminar

Single proprietorship

 Corporation
Contract of lease
Picture of drugstore with signboard

Location plan and floor plan with dimension

Opening fee ( A.O. 50 s. 2001)

Requirement
Petition Form

Requirement
Joint Affidavit of

Undertaking

List of Tentative Products

Example

Paracetamol
Biogesic
Tempra
Tylenol
Winadol
Acetadol
Rexidol

License To Operate

Pharmacist
Registration of

certificate

Pharmacist
Business Registration

Pharmacist
PRC ID

Pharmacist
Certificate of attendance

REFERENCE BOOKS

PNDF
RA 3720
RA 6675
RA 5921
RA 8203
USP/NF
RPS
Goodman and Gilman Pharmacological Basis
of Therapeutics

Reference Book
Philippine National Drug

Formulary

Reference Book
Remington

Pharmaceutical
Sciences

Reference Book
UNITED STATE

PHARMACOPEIA

RECORD BOOKS
Prescription Book
Dangerous Drug Book
Poison Book

Exempt Preparation Book

Prescription Book

Prescription Book

Dangerous Drugs Book

DANGEROUS DRUG BOOK

POISON/CHEMICAL BOOK

OPIUM BOOK

PRESCRIPTION BOOK

INTERNSHIP 1

By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.

EXERCISE NO. 2

THE CONTROL OF
PHARMACY
PROFESSION

Terms To Define
STATUTORY LAW
COMMON LAW
ETHICS

REGULATORY LAW
JURISPRUDENCE

STATUTORY LAWS AFFECTING

PHARMACY PROFESSION
RA 5921 JUNE 22, 1969
RA 3720 JUNE 23, 1963
RA 8203 SEPT 4, 1996
RA 6675 1988
RA 9165 2002, repealing RA 6425
RA 9257 (Expanded Senior Citizen Act)
amending RA 7432
RA 7581 PRICE ACT
RA 7394 CONSUMERS ACT

THE PHARMACY LAW R.A. 5921

is an act regulating the

practice of pharmacy and
setting standards of
pharmaceutical education in
the Philippines and other
purposes

THE FOODS, DRUGS & DEVICES R.A. 3720

this is an act to ensure the safety

and purity of foods and cosmetics,
and the purity, safety, efficacy, and
quality of drugs and devices being
made available to the public vesting
the BFAD with authority to administer
and enforce the laws pertaining
thereto

SPECIAL LAW ON COUNTERFEIT

DRUGS R.A. 8203
It is an act prohibiting counterfeit
drugs,
providing
penalties
for
violations and appropriating funds.
The BFAD of the Department of
Health is authorized to administer
and supervise the implementation of
this Act which was approved on
September 4, 1996.

THE GENERICS ACT R.A. 6675

It is act to promote, require, and

ensure the production of an
adequate supply, distribution, use
and acceptance of drugs and
medicines identified by their
generic names.

COMPREHENSIVE DANGEROUS
DRUG ACT R.A. 9165

It is an act instituting the

Comprehensive Dangerous
Drugs Act of 2002, repealing
Republic Act No. 6425,
otherwise known as the
Dangerous Drugs Act of 1972

EXPANDED SENIOR CITIZEN ACT

R.A. 9257
An act granting additional benefits
and privileges to senior citizens
amending for the purpose RA No.
7432, otherwise known as An act to
maximize the contribution of senior
citizens to nation building, grant
benefits and special privileges and for
other purposes

THE PRICE ACT R.A. 7581

An act providing protection to
consumers by stabilizing the prices of
basic
necessities
and
prime
commodities and by prescribing
measures
against
undue
price
increases during emergency situations
and like occasions
.

CONSUMERS ACT R.A. 7394

It is an act to protect the

interest of the consumer,
promote his general welfare
and to establish standards of
conduct for business and
industry.
.

PRINCIPLES OF PROFESSIONAL
CONDUCT
Service to others
Integrity and Objectivity
Professional competence

Solidarity and teamwork

Social and civic responsibility
Global competitiveness
Equality of all professions

CODE OF ETHICS
IMPORTANCE

States publicly the principles that form the

fundamental basis of pharmacists roles and
responsibilities
Guides them in their relationship with patients,
health professionals and society

INTERNSHIP 1

By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.

EXERCISE 3

THE COMMUNITY
PHARMACY
PROFILE

 TRADITIONAL MARKET
DRUGSTORE

 PERSONNEL
STORE HOURS
NON-TRADITIONAL MARKET

STORE FRONT LAYOUTS

DRUGSTORE CHAIN OPERATION
MERCHANDISE &SERVICES

WAYS OF DEVELOPING COMPETITIVE

ADVANTAGES
IN
COMMUNITY
PHARMACY
Product line assortment
Leader pricing strategy
Innovation of operation

Customer services
Equipment /facilities

COMPARISON OF COMMUNITY
PHARMACY IN 1990S AND 2000S
Location
signboards

 Store front and interiors

Staffing pattern
Pharmacist

 Communication

Store facilities

Capitalization
Transportation

BEING FIRST TO INTRODUCE

24 HOUR SERVICE

BEING FIRST MOTORIZED

CUSTOMER DELIVERY

BEING FIRST COMPUTERIZED

TEMPERATURE CONTROLLED WAREHOUSE

BEING FIRST COMMUNITY PHARMACY

INSIDE SHOPPING MALLS AND
SUPERMARKETS

BEING FIRST MODERNIZE STORE FRONT,

INTERIORS WAREHOUSE AND LAYOUT

BEING FIRST MEDICAL-PHARMACY

OUTREACH MISSION

BEING FIRST DRUGSTORE CHAIN

TO EXPAND THROUGHOUT

BEING FIRST PROFESSIONALIZE ITS

PERSONNEL

INTERNSHIP 1

By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.

Exercise 4

THERAPEUTIC
CATEGORIES OF
DRUGS BY PNDF

 PNDF
DANGEROUS DRUGS
BFAD

THERAPEUTIC COMMITTEES
CORE/ MAIN LIST
COMPLEMENTARY LIST

GENERAL GUIDELINES FOR

ESTABLISHING PNDF
Relevance to disease
Efficacy and safety
Quality
Cost
Appropriateness to capability of health

workers at different levels of health care

 Local health problems

Benefit/risk ratio
Preferential factors for evaluating

therapeutically equivalent drugs

Drugs formulated as single compounds
Period review of drug list

Criteria for inclusion of drugs into

PNDF
Drug is needed for prevention and Tx of

conditions not already covered in existing list

Drug is more effective / less toxic than the
drug listed for same medication
Drug is at least as effective and safe and of
lower cost than the drug listed for same
indication
Drug is essential for specific DOH health
project

Criteria for deletion of drugs from

PNDF
A more effective or equally effective but less

toxic drug becomes available

The therapeutic efficacy of drug is found to be
unsatisfactory or questionable
Toxicity/suspected toxicity or potential for
abuse or dangerous interactions outweigh its
therapeutic value
Disuse of drug and no longer available

 The drug is no longer deemed cost-effective

to other therapies
The drug is a fixed dose combination which
does not satisfy the requirements of AO 96 s.
1990

Core List
Acetylcysteine
Azathioprine
Clofazimine
Cobra antivenin
Dantrolene
Diazepam
Diethylcarbamazepine
Diphtheria-tetanus toxoids
Dimercaprol
endrophonium

Ergocalciferol
Fluorecein
Folic acid
Hydrochlorthiazide
Hydrocortisone
Hydroxycobalamine
Indomethacin inj
Iodine
INH + ethambutol
INH + rifampicin

INH+ Rifampicin+ PZA

Levodopa + Thiacetazone
Lorazepam
Methylene blue
N-acetyl penicillamine
Neostigmine
Nicotinamide
ORS 75 replacement
Potassium
Pot. phosphate

Praziquantrel
Retinol
Na Ca edetate
NaI 131I
Na nitrite
Na nitroprusside
Na thiosulfate
Succimer
Thiamine
Tuberculin purified protein
derivative

Complementary List
Aciclovir eye ointment
Alpha-tocopherol
Al acetate
Cromolyn
Buserelin
Busulfan
Chloral hydrate
Chlormethine
Dithranol

estramustine

Hydroxycobalamin
Indomethacin
Iodamide
Iron dextran
Povidone iodide
Pralidoxime Cl
Pyrimethamine
Recombinant tissue
plasminogen activator
Rifabutin
Rose bengal

Silver nitrate

Varicella zoster Ig

Spectinomycin

Vasopressin

Terizodone

Yerba buena

Tetracosactide

Zinc

Thiacetazone

Drugs in PNDF with special

requirements
Dangerous Drugs (A1)

Alprazolam
Bromazepam

Morphine
Nalbuphine

Butorphanol
Clonazepam
Codein
Diazepam
Fentanyl
Lorazepam
Methylphenidate
midazolam

Oxycodone
Pethidine (meperidine)
Phenobarbital
Thiopenthal Na
Tramadol
Zolpidem

 Controlled precursors and Essential

chemicals (A2)

Ephedrine
Ergotamine
PPA

Medicinal products listed with BFAD

Akapulko
Lagundi
Sambong

Tsaang gubat
Yerba buena